If none of these apply and the peptide still has not dissolved after 30-45 minutes, contact the supplier
The lyophilized powder is stable as shipped
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Intramuscular injections are touted as being easier to administer than intravenous, partly because of the easy access of the thigh muscles
An untrained injector can provoke mild or moderate to severe side effects with incorrect administration
Across this body of literature the compound has been described under several names: pentadecapeptide BPC-157, the full Body Protection Compound 157, the early trial designation PL 14736, and the proprietary name Bepecin used in early Croatian pharmaceutical work
